1 / 40

Antiviral Properties of Milk Proteins and Peptides

Antiviral Properties of Milk Proteins and Peptides. RAVINDER NAGPAL 1 , CHAITANYA. S 1 , MONICA PUNIYA 2 , AARTI BHARDWAJ 3 , SHALINI JAIN 4 AND HARIOM YADAV 4* 1 Dairy Microbiology, 2 Dairy Cattle Nutrition, 4 Animal Biochemistry, National Dairy Research Institute, Karnal 132001,

verna
Download Presentation

Antiviral Properties of Milk Proteins and Peptides

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antiviral Properties of Milk Proteins and Peptides RAVINDER NAGPAL1, CHAITANYA. S1, MONICA PUNIYA2, AARTI BHARDWAJ3, SHALINI JAIN4 AND HARIOM YADAV4* 1Dairy Microbiology, 2Dairy Cattle Nutrition, 4Animal Biochemistry, National Dairy Research Institute, Karnal 132001, Haryana, Meerut Institute of Engineering and Technology, Meerut-250002, U.P., India. *Email: yadavhariom@gmail.com

  2. Introduction • Milk proteins and peptides possess biological properties beyond their nutritional significance • In 1987, lactoferrin (LF) -Friend leukaemia virus (FLV) • Chemically modified milk proteins & peptides

  3. Proteins with Antiviral activity: • Lactoferrin (LF) • Lactadherin • Glycoprotein • Immunoglobulin (Ig)

  4. Lactoferrin (LF) • Multifunctional Iron binding glycoprotein • Released in the stomach by pepsin cleavage at acidic pH • LF - Antiviral activity against both DNA and RNA viruses

  5. ACTION OF LF-ENVELOPED VIRUSES: • Human immunodeficiency virus (HIV) • Human cytomegalovirus (CMV) • Herpes simplex virus type 1 and 2 (HSV) • Hepatitis B, C and G viruses • Human papillomavirus (HPV) and • Alphavirus

  6. - NON-ENVELOPED VIRUSES: • Rotavirus • Enterovirus • Poliovirus • Adenovirus and • Feline calicivirus

  7. Antiviral effect of proteins

  8. Antiviral mechanisms of LF

  9. Mechanismof action • First, LF appears to interact with the receptors on the cell surface, such as glycosaminoglycans which are the binding sites for many viruses • Second, LF binds directly to viral particles and inhibits viral adsorption to target cells

  10. Antiviral effectiveness: • The differences in amino acid sequence of antiviral region • Glycan chains and the number of disulphide bridges between hLF and bLF • HIV, HSV, CMV and adenovirus, recognise cell-surface proteoglycans (heparin and heparan sulphate) as receptors

  11. HIV-1 entry into the target cells • Mediated by glycoprotein gp-120 and gp-41 • CD4 -receptor and CCRS, CXCR4 – co receptors • Fusion of viral and cellular membranes

  12. Contd… • Interaction between the V3 loop and heparan sulfate adhere virus to the cell surface • Positively charged compounds (AMD3100 and ALX40-4C) block HIV-1 replication, interact with negatively charged CXCR4 coreceptors

  13. PURIFICATION OF BOVINE MILK PROTEINS ANDPEPTIDES α-S2 Casein, bovine LFcin-B and bovine k-casein Hydrolysis with pepsin Cation exchange chromatography Obtained fragments characterized by HPLC and ESI-MS

  14. Contd… • Βovine β-casein and bovine β lactoglobulin are modified by maleic acid (Ikura et al., 1984) • Bovine as2-casein is modified with 3-hydroxyphthalic anhydride • The degree of modification checked with ortho-phtaldialdehyde (Berkhout et al., 1997)

  15. Methods to check antiviral properties • ELISA • MTT ASSAY • RADIOISOTOPING METHOD

  16. 1. ELISA Add milk protein(1-10 µM ),before addition of HIV-1 virus sup T1 T cell line grown in RPMI medium with 10% FCS at 37 ºC in 5% co2 Virus harvested at peak production and stored at - 70 ºc Quantified in a CA-P24 antigen ELISA

  17. 2. MTT ASSAY MT2 T cell line infected with HIV-1 LA1 - increased concentration of milk proteins After 5 days post-infection Living cells convert the MTT {3-(4,5-dimethylethiazole-2-ly)-2,5-diphenyltetrazolium bromide) Blue product (formazine)

  18. 3. RADIOISOTOPING METHOD Cell culture vessel (Nunclon 24-well plate) Nonspecific protein-inhibitors Add sup T1 cells in a complete medium (RPMI) Radioactively labelled 125 I-bLF & incubate plates at 4 ºc to 37 ºc for 1 hour Amount of radioactvity recovered was determined by GAMMA COUNTER

  19. LACTOFERRIN RESISTANCE • HIV-1 LA1 isolate cultured in the presence of 10µM bLF • Cell free virus is passaged on to uninfected supT1 cells • Observe the massive syncytia formation in culture • Virus sample is taken after several days

  20. Contd… 5. Tested for parallel infection with & without LF 6. Infected cells frozen at -80 ºc for subsequent DNA analysis 7. PCR amplified , Gel purified & Cloned into a cloning vector 8. Multiple clones are inserted as Bam H1 fragment into the PLA I molecular clone 9. Tested their replication capacity with and without bLF

  21. PURIFIED MILK PROTEINS & THEIR EFFECT ON HIV-1 REPLICATION • No antiviral activity with the negatively charged peptides • b-casein 1-28 • kcasein 1-10 and • CMP-A and CMP- B at 10 mM • Complete viral inhibition - chemically modified negatively charged milk protein 3HP-CN

  22. Contd… • Positively charged peptides nisin and lactoferricin • 10 µM - moderately inhibit HIV-1 • 100 µM - complete inhibition but cytotoxicity is observed • bLF significantly inhibits at 0.1-1.0 µMconc • Human LF- both native protein and recombinant protein moderately act as inhibitors at 3.1 µM conc

  23. LACTOFERRIN INHIBITION OF CXCR4 & CCR5-using viruses • Lactoferrin has both positively & negatively charged domains at physiological pH • That will interfere with the virus –coreceptor interaction • These HIV-1 used to infect U87CD4 cell line that was transfected either CXCR4/CCR5

  24. Contd… • bLF is a superior anti-HIV-1 compound compared to human LF and murine LF either of their native or recombinant proteins • bLF is 69% and 64% identical to hLF and mLF respectively • Bovine Plasma and milk proteins are abundantly available • These industrial proteins are produced at a large scale, through simple chemical modifications

  25. Contd… • provide relatively cheap antivirals for systemic or local administration • Systemic use of chemically modified milk proteins in human may face major toxicity and immunogenicity problems • except suc-HAS & 3HP-LA show low level toxicity & immunogenicity

  26. Antiviral properties of other milk proteins • Lactadherin • Glycoprotein • Immunoglobulin (Ig)

  27. Lactadherin: • Viral receptor binding • sialic acid plays important role in its antiviral action • Human lactadherin protected breast-fed infants against symptomatic rotavirus infection

  28. Glycoprotein : • High-molecular weight fraction from bovine milk • was effective against human rotavirus in vitro • Milk immunoglobulin : • Hyperimmunised with human rotavirus during pregnency of cows • 100 times- Human milk • 10 times – Commercial Ig

  29. Antiviral peptides derived from milk proteins • Lactoferricin • GMP • Mucin complex

  30. Antiviral effect of peptides

  31. Enhancement of Antiviral activity on Chemical modification • Chemical modifications lead to changes in the charges on milk proteins which can enhance their antiviral properties (Swart, Harmsen, et al., 1999; Waarts et al., 2005) • Two main approaches: • Acylation to increase negative charges • Amination to increase positive charges

  32. Contd… • Succinylated and aconitylated LF has stronger anti-HIV-1 effects (2-4 times more active than native LF) (Swart, Harmsen, et al.,1999) • Several other proteins - b-Lg, a-La and HSA, also has an enhanced effect against HIV-1 and HIV-2 (Jiang, Lin, Strick, Li, & Neurath, 1996) • Additional negative charges were introduced through modifications of lysine residues

  33. Contd… • b-Lg modified with 3- hydroxyphthaloyl acid (3HP) interfered with the infection by HIV-1, HSV-1 & 2, and HCMV (Berkhout et al., 2002; Swart, Kuipers, et al., 1996) • It was also found that 3HP-a-La and 3HP-as2-casein were also effective against HIV-1

  34. Contd… • 3-HP-b-Lg might be an efficacious agent for preventing vaginal transmission of genital herpes virus infections • Increasing positive net charge on LF • Amination abrogated its anti-HIV effect but increased anti- HCMV effect • Acylation abolished anti-HCMV propertiesof LF but effective against influenza virus

  35. Conclusion • Dietary Milk proteins improve the health of patients suffering from viral infections • Bovine LF showed considerable inhibitory action against most of the viruses • Results of research undertaken to date, primarily under in vitro conditions • In more recent years, in vivo effects have been reported in mouse and rat models

  36. Contd… • In the immediate future, for prevention and therapy of viral infections in animals and humans • Benefits of some of the chemical modifications observed in vitro could be explored • For Specific applications in animal and human health care

More Related